Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,720 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mechanical prophylaxis is a heparin-independent risk for anti-platelet factor 4/heparin antibody formation after orthopedic surgery.
Bito S, Miyata S, Migita K, Nakamura M, Shinohara K, Sato T, Tonai T, Shimizu M, Shibata Y, Kishi K, Kubota C, Nakahara S, Mori T, Ikeda K, Ota S, Minamizaki T, Yamada S, Shiota N, Kamei M, Motokawa S. Bito S, et al. Among authors: shibata y. Blood. 2016 Feb 25;127(8):1036-43. doi: 10.1182/blood-2015-06-651620. Epub 2015 Dec 9. Blood. 2016. PMID: 26659923 Free PMC article.
Effects of enteral nutrition and parenteral nutrition on survival in patients with advanced cancer cachexia: Analysis of a multicenter prospective cohort study.
Amano K, Maeda I, Ishiki H, Miura T, Hatano Y, Tsukuura H, Taniyama T, Matsumoto Y, Matsuda Y, Kohara H, Morita T, Mori M; East-Asian collaborative cross-cultural Study to Elucidate the Dying process (EASED) Investigators. Amano K, et al. Clin Nutr. 2021 Mar;40(3):1168-1175. doi: 10.1016/j.clnu.2020.07.027. Epub 2020 Jul 31. Clin Nutr. 2021. PMID: 32771283
Effects of parenteral nutrition and hydration on survival in advanced cancer patients with malignant bowel obstruction: secondary analysis of a multicenter prospective cohort study.
Arakawa S, Amano K, Oyamada S, Maeda I, Ishiki H, Miura T, Hatano Y, Naito AS, Sato M, Ito T, Kosugi K, Miyake S, Morita T, Mori M; East-Asian Collaborative Cross-Cultural Study To Elucidate the Dying Process (EASED) Investigators. Arakawa S, et al. Support Care Cancer. 2021 Dec;29(12):7541-7549. doi: 10.1007/s00520-021-06293-8. Epub 2021 Jun 10. Support Care Cancer. 2021. PMID: 34114097
Twenty-Four-Month Safety and Effectiveness of TCD-17187 Drug-Coated Balloon for Treatment of Atherosclerotic Lesions in Superficial Femoral and Proximal Popliteal Artery.
Soga Y, Iida O, Seki SI, Kawasaki D, Anzai H, Ando H, Nakama T, Shinozaki N, Kozuki A, Ishihara M, Urasawa K, Toi S, Tsujita H, Tobita K, Ogata K, Horie K, Hayakawa N, Mori S, Fujihara M, Ohki T, Yuba K, Mano T, Ando K, Nakamura M; TCD-17187 Japan Investigators. Soga Y, et al. Cardiovasc Intervent Radiol. 2024 May 30. doi: 10.1007/s00270-024-03747-4. Online ahead of print. Cardiovasc Intervent Radiol. 2024. PMID: 38816504
Epidemiological study of Respiratory syncytial virus infection in adults during the pandemic of COVID-19.
Asai N, Shibata Y, Yamada A, Ohashi W, Takayama M, Kawamoto Y, Miyazaki N, Sakanashi D, Ohno T, Nakamura A, Koita I, Suematsu H, Chida S, Ohta T, Kato H, Hagihara M, Hirai J, Mori N, Mikamo H. Asai N, et al. Among authors: shibata y. J Infect Chemother. 2024 May 21:S1341-321X(24)00130-2. doi: 10.1016/j.jiac.2024.05.004. Online ahead of print. J Infect Chemother. 2024. PMID: 38782237
Simple prediction tools for disease progression in unvaccinated patients with mild/moderate COVID-19 aged under 65 years: Simplified DOATS and DOAT scores.
Shibata Y, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Rikimaru M, Kawamata T, Togawa R, Sato Y, Saito J, Kanazawa K, Iseki K; Doctors in Fukushima and Yamagata against COVID-19. Shibata Y, et al. Respir Investig. 2024 May 22;62(4):681-684. doi: 10.1016/j.resinv.2024.05.006. Online ahead of print. Respir Investig. 2024. PMID: 38781788
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based Immunotherapies.
Beebe KD, Eisner JR, Guo J, Shibata Y, Davison JM, Uronis J, Farhangfar C, Farhangfar F, Mooney J, Milburn MV, White RL, Amin A, Milla ME, Foureau DM. Beebe KD, et al. Among authors: shibata y. J Immunol. 2024 May 20:ji2300736. doi: 10.4049/jimmunol.2300736. Online ahead of print. J Immunol. 2024. PMID: 38767437
2,720 results